# Line Intensity Mapping Prediction from the Cosmic Dawn (CoDa) III Simulation for H$α$ from Galaxies and the Intergalactic Medium during the Epoch of Reionization

Article · Eugene Hyeonmin Lee, Joohyun Lee, Paul R. Shapiro, Pierre Ocvirk, Joseph S. W. Lewis, Taha Dawoodbhoy, Ilian T. Iliev, Luke Conaboy, Kyungjin Ahn, Hyunbae Park, Jenny G. Sorce, Dominique Aubert, Romain Teyssier, Gustavo Yepes, Yohan Dubois, Stefan Gottlöber

- Archive id: arxiv:2504.15821
- Published: 2025-04-19
- Venue: Res. Notes AAS, 9, 96 (2025)
- DOI: https://doi.org/10.3847/2515-5172/adcea7
- arXiv: https://arxiv.org/abs/2504.15821
- Citations: 2
- Source URL: https://arxiv.org/abs/2504.15821
- PDF: https://arxiv.org/pdf/2504.15821
- Provenance: arxiv

## Abstract

The evolution of large-scale structure, galaxies and the intergalactic medium (IGM) during the Epoch of Reionization (EoR) can be probed by upcoming Line Intensity Mapping (LIM) experiments, which sample in redshift and direction without needing to resolve individual galaxies. We predict the intensity and sources of hydrogen H$α$ emission, dominated by radiative recombination following ionization by UV from the same massive stars that caused reionization, down to redshift 4.6, using the largest fully-coupled, radiation-hydro simulation of galaxy formation and reionization to date, Cosmic Dawn (CoDa) III. We compute the mean intensity and Voxel Intensity Distribution (VID) vs. redshift, including the relative contributions of galaxies and IGM. This will provide mock data to guide and interpret LIM experiments such as NASA's SPHEREx and proposed Cosmic Dawn Intensity Mapper (CDIM).

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

Topics: [JWST & the Early Universe](https://space-kitty.com/topics/early-universe-jwst)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.